Rapid reversal of coagulopathy in warfarin-related intracranial haemorrhages with prothrombin complex concentrates

Anaesthesia and Intensive Care

Volumn 38, Issue 3, 2010, Pages 474-480

  Chong, C T ^a,b   Lew, T W K ^a,b   Kuperan, P ^a,b   Tan, J J E ^a,b   Tan, H L ^a,b   Kwek, T K ^a,b  

^a TAN TOCK SENG HOSPITAL   (Singapore)

^b Department of Anaesthesiology ^*  (Singapore)

Author keywords

Intracerebral haemorrhage; Intracranial haemorrhage; Oral anticoagulant therapy; Prothrombin complex concentrates; Warfarin

Indexed keywords

BLOOD CLOTTING FACTOR 9 COMPLEX; FRESH FROZEN PLASMA; RECOMBINANT BLOOD CLOTTING FACTOR 7A; VITAMIN K GROUP; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARTERY THROMBOSIS; ARTICLE; BLOOD CLOTTING DISORDER; BRAIN HEMATOMA; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CORONARY ARTERY THROMBOSIS; DEEP VEIN THROMBOSIS; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; SUBDURAL HEMATOMA; SUPERFICIAL THROMBOPHLEBITIS;

AGED; ANTICOAGULANTS; BLOOD COAGULATION FACTORS; CEREBRAL HEMORRHAGE; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; WARFARIN;

EID: 77953016014     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Hart RG, Boop BS, Anderson DC. Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke 1995; 26:1471-1477.
2. Rosand J, Eckman MH, Knudsen KA, Singer DE, Greenberg SM. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med 2004; 164:880-884. (Pubitemid 38520629)
3. Franke CL, de Jonge J, van Swieten JC, Op de Coul AA, van Gijn J. Intracerebral hematomas during anticoagulant treatment. Stroke 1990; 21:726-730.
4. Weimar C, Weber C, Wagner M, Busse O, Haberl RL, Lauterbach KW et al. Management patterns and health care use after intracerebral hemorrhage. A cost-of-illness study from a societal perspective in Germany. Cerebrovasc Dis 2003; 15:29-36.
5. Flibotte JJ, Hagan N, O'Donnell J, Greenberg SM, Rosand J. Warfarin hematoma expansion, and outcome of intracerebral hemorrhage. Neurology 2004; 63:1059-1064. (Pubitemid 39287915)
6. Hart RG. What causes intracerebral hemorrhage during warfarin therapy? Neurology 2000; 55:907-908.
7. Leissinger CA, Blatt PM, Hoots WK, Ewenstein B. Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature. Am J Hematol 2008; 83:137-143.
8. Albers GW, Sherman DG, Gress DR, Paulseth JE, Petersen P. Stroke prevention in nonvalvular atrial fibrillation: a review of prospective randomized trials. Ann Neurol 1991; 30:511-518.
9. Davis SM, Broderick JP, Hennerici M, Brun NC, Diringer MN, Mayer SA et al. Hematoma growth is determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology 2006; 66:1775-1781. (Pubitemid 43739699)
10. Barnette RE, Wendling WW, Schweiger JW, Brister NW, Schartel SA, Chen D et al. Intravenous vitamin K1 prior to orthotopic heart transplantation: effects in vivo and in vitro. Acta Anaesthesiol Scand 1997; 41:78-83. (Pubitemid 27077153)
11. Goldstein JN, Thomas SH, Frontiero V, Joseph A, Engel C, Snider R et al. Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage. Stroke 2006; 37:151-155. (Pubitemid 43732064)
12. Fredriksson K, Norrving B, Stromblad LG. Emergency reversal of anticoagulation after intracerebral hemorrhage. Stroke 1992; 23:972-977.
13. Carthill M, Dolan G, Byrne JL, Byrn PO. Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies. Br J Neurosurg 2000; 14:458-461.
14. Makris M, Greaves M, Phillips WS, Kitchen S, Rosendaal FR, Preston EF. Emergency oral anticoagulant reversal: The relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb Haemost 1997; 77:477-480. (Pubitemid 27121012)
15. Boulis NM, Bobek MP, Schmaier A, Hoff JT. Use of factor IX complex in warfarin-related intracranial hemorrhage. Neurosurgery 1999; 45:1113-1118.
16. Huttner HB, Schellinger PD, Hartmann M, Köhrmann M, Juettler E, Wikner J et al. Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy. Comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates. Stroke 2006; 37:1465-1470.
17. Guidelines on oral anticoagulation: third edition. Br J Haematol 1998; 101:374-387.
18. Baker RI, Coughlin PB, Gallus AS, Harper PL, Salem HH, Wood EM et al. Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of thrombosis and hemostasis. Med J Aust 2004; 181:492-497.
19. van Aart L, Eijkhout HW, Kamphuis JS, Dam M, Schattenkerk ME, Schouten TJ et al. Individualized dosing regimen for prothrombin complex concentrate more effective than standard treatment in the reversal of oral anticoagulant therapy: an open, prospective randomized controlled trial. Thromb Res 2006; 118:313-320.
20. Yasaka M, Sakata T, Naritomi H, Minematsu K. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation. Thromb Res 2005; 115:455-459.
21. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2008; 358:2127-2137.
22. Hemphill III JC. Treating warfarin-related intracerebral hemorrhage: is fresh frozen plasma enough? Stroke 2006; 37:6-7.
23. Dentali F, Ageno W, Crowther M. Treatment of coumarin-associated coagulopathy: a systematic review and proposed treatment algorithms. J Thromb Haemost 2006; 4:1853-1863.